Continuous-Flow Pumps in Pediatric Population

Martin Schweiger; Daniel Zimpfer; Gaetano Gargiulo; Michael Hübler

doi:10.1007/978-3-319-43383-7_36

Continuous-Flow Pumps in Pediatric Population

Martin Schweiger
, Daniel Zimpfer
, Gaetano Gargiulo
, Michael Hübler

School of Engineering, Design & Built Environment

Department of Congenital Pediatric Surgery
Medical University of Vienna

Research output: Chapter in Book / Conference Paper › Chapter › peer-review

Abstract

The introduction of continuous-flow (cf) technology in mechanical circulatory support has expanded the armamentarium of VAD options and is nowadays considered the first-line therapy in adults. Miniaturization of pump design has made it a promising option to reduce morbidity and overcome the need for hospitalization for the pediatric population. Implantation in older children became feasible and improved the quality of life. The quest now goes to children even below BSA 1m2. This chapter summarizes the increasing experiences gained so far worldwide by using cf-VADs in children. Furthermore, the application of two cf-VADs working as intracorporeal BVAD is discussed as well as adults suffering from congenital heart defects suffering from heart failure (CHD).

Original language	English
Title of host publication	Mechanical Circulatory Support in End-Stage Heart Failure
Subtitle of host publication	A Practical Manual
Publisher	Springer Science+Business Media
Pages	361-369
Number of pages	9
ISBN (Electronic)	9783319433837
ISBN (Print)	9783319433813
DOIs	https://doi.org/10.1007/978-3-319-43383-7_36
Publication status	Published - 1 Jan 2017

Bibliographical note

Publisher Copyright:
© Springer International Publishing Switzerland 2017.

Keywords

Congenital heart defects
Continuous-flow VADs
Intracorporeal VADs
Pediatric

Access to Document

10.1007/978-3-319-43383-7_36

Cite this

@inbook{b0296240c99942f388679380b35f00d1,

title = "Continuous-Flow Pumps in Pediatric Population",

abstract = "The introduction of continuous-flow (cf) technology in mechanical circulatory support has expanded the armamentarium of VAD options and is nowadays considered the first-line therapy in adults. Miniaturization of pump design has made it a promising option to reduce morbidity and overcome the need for hospitalization for the pediatric population. Implantation in older children became feasible and improved the quality of life. The quest now goes to children even below BSA 1m2. This chapter summarizes the increasing experiences gained so far worldwide by using cf-VADs in children. Furthermore, the application of two cf-VADs working as intracorporeal BVAD is discussed as well as adults suffering from congenital heart defects suffering from heart failure (CHD).",

keywords = "Congenital heart defects, Continuous-flow VADs, Intracorporeal VADs, Pediatric",

author = "Martin Schweiger and Daniel Zimpfer and Gaetano Gargiulo and Michael H{\"u}bler",

note = "Publisher Copyright: {\textcopyright} Springer International Publishing Switzerland 2017.",

year = "2017",

month = jan,

day = "1",

doi = "10.1007/978-3-319-43383-7\_36",

language = "English",

isbn = "9783319433813",

pages = "361--369",

booktitle = "Mechanical Circulatory Support in End-Stage Heart Failure",

publisher = "Springer Science+Business Media",

}

TY - CHAP

T1 - Continuous-Flow Pumps in Pediatric Population

AU - Schweiger, Martin

AU - Zimpfer, Daniel

AU - Gargiulo, Gaetano

AU - Hübler, Michael

N1 - Publisher Copyright: © Springer International Publishing Switzerland 2017.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The introduction of continuous-flow (cf) technology in mechanical circulatory support has expanded the armamentarium of VAD options and is nowadays considered the first-line therapy in adults. Miniaturization of pump design has made it a promising option to reduce morbidity and overcome the need for hospitalization for the pediatric population. Implantation in older children became feasible and improved the quality of life. The quest now goes to children even below BSA 1m2. This chapter summarizes the increasing experiences gained so far worldwide by using cf-VADs in children. Furthermore, the application of two cf-VADs working as intracorporeal BVAD is discussed as well as adults suffering from congenital heart defects suffering from heart failure (CHD).

AB - The introduction of continuous-flow (cf) technology in mechanical circulatory support has expanded the armamentarium of VAD options and is nowadays considered the first-line therapy in adults. Miniaturization of pump design has made it a promising option to reduce morbidity and overcome the need for hospitalization for the pediatric population. Implantation in older children became feasible and improved the quality of life. The quest now goes to children even below BSA 1m2. This chapter summarizes the increasing experiences gained so far worldwide by using cf-VADs in children. Furthermore, the application of two cf-VADs working as intracorporeal BVAD is discussed as well as adults suffering from congenital heart defects suffering from heart failure (CHD).

KW - Congenital heart defects

KW - Continuous-flow VADs

KW - Intracorporeal VADs

KW - Pediatric

UR - https://www.scopus.com/pages/publications/105009074460

U2 - 10.1007/978-3-319-43383-7_36

DO - 10.1007/978-3-319-43383-7_36

M3 - Chapter

AN - SCOPUS:105009074460

SN - 9783319433813

SP - 361

EP - 369

BT - Mechanical Circulatory Support in End-Stage Heart Failure

PB - Springer Science+Business Media

ER -

Continuous-Flow Pumps in Pediatric Population

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this